Status:

COMPLETED

AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Cardiac Surgery

Cardiopulmonary Bypass

Eligibility:

All Genders

18+ years

Brief Summary

In this before-after multicenter study the authors tested the hypothesis that the prophylactic use of aprotinin compared to tranexamic acid could reduce the proportion of patients presenting severe pe...

Detailed Description

Perioperative bleeding remains a real challenge for physicians managing cardiac surgical patients. In patients at high risk for excessive bleeding the prophylactic use of antifibrinolytics may be usef...

Eligibility Criteria

Inclusion

  • patients undergoing cardiac on pump surgery at high risk for bleeding defined by :
  • Aorto-coronary bypasses surgery (2 or more) under dual platelet aggregation therapy (Primary or redo)
  • Heart transplant (Primary or Redo)
  • Infectious endocarditis (Primary or Redo)
  • Ascending acute aortic dissection (Primary or Redo)
  • Artificial heart / LVAD under CEC (Primary or Redo)
  • Combined surgery, Redo
  • Ascending aorta surgery, Redo

Exclusion

  • Off pump cardiac surgery
  • Patient not meeting the inclusion criteria
  • Patient not receiving antifibrinolytic therapy
  • Patient with absolute contraindication to antifibrinolytics,
  • Patient refusing to give access to their medical chart,
  • Patient not meeting the inclusion criteria
  • Patient protected by the law, under guardianship or trusteeship,
  • Patient deprived of liberty

Key Trial Info

Start Date :

March 31 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 31 2021

Estimated Enrollment :

693 Patients enrolled

Trial Details

Trial ID

NCT04804345

Start Date

March 31 2021

End Date

August 31 2021

Last Update

March 3 2022

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Grenoble University Hospital

La Tronche, France, 38700

2

Lyon University Hospital

Lyon, France, 69500

3

Montpellier University Hospital

Montpellier, France, 34295

4

Nantes University Hospital

Nantes, France, 44093

AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding | DecenTrialz